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A B S T R A C T   
Background: Transdiagnostic iCBT has been shown to be effective for the treatment of emotional disorders. Less is 
known about the optimal level of therapist and patient involvement in these interventions. Specific character-
istics of Internet-delivered interventions include treatment adherence (e.g., amount of review of the materials) 
and guidance (e.g., amount of therapist support). Exploring the importance of these elements in treatment 
outcome may help to maximize the efficiency of Internet-delivered psychological interventions. 
Aim: In this study, we aimed to analyze the relationship between patient and therapist involvement (i.e., platform 
usage and amount of therapist guidance) in a sample of patients with emotional disorders who received trans-
diagnostic iCBT in Spanish public specialized mental healthcare services. 
Method: This is a secondary analysis of a randomized controlled trial. The sample included 63 patients who 
completed transdiagnostic iCBT for emotional disorders. Platform usage metrics included number of logins into 
the platform and number of times the participants reviewed the modules. Therapist guidance was measured as 
the number of support phone calls with a therapist and their total duration (minutes). Logistic regressions and 
ROC analyses were performed to explore the predictive value of platform usage and therapist guidance in 
symptom reduction. Clinical outcomes included depressive and anxiety symptoms assessed at baseline and post- 
intervention. The bivariate relationship between the platform usage and therapist guidance variables was also 
explored. 
Results: Overall, platform usage and therapist guidance were not associated with symptom improvement. 
However, the patient and therapist involvement parameters were intercorrelated. Specifically, the number of 
calls and their duration were associated with a greater number of logins (r = 0.61; p < .001) and more frequent 
reviews of the modules (0.46 ≤ r ≤ 0.60; p < .001). Higher baseline depression and anxiety were, respectively, 
associated with greater improvements in depression (r = − 0.37, p = .003) and anxiety after treatment 
completion (r = − 0.48, p < .001). 
Discussion: The results suggest that there is no reliable cut-off point for platform usage and therapist guidance in 
predicting optimal symptom reduction. However, significant associations were found between platform usage 
and guidance variables that warrant additional research. More research on this topic is necessary to further 
clarify the role of these and other platform usage and guidance variables in Internet-delivered iCBT outcomes.   
1. Introduction 
Anxiety and depressive disorders are the most common emotional 
disorders (Bullis et al., 2019) and represent a global mental health 
concern due to their alarming prevalence rates and associated 
consequences in terms of economic costs and emotional suffering 
(Baxter et al., 2014; Lim et al., 2018). In this scenario, for decades, re-
searchers have claimed that efforts should be made to find more 
accessible, evidence-based psychotherapies for these disorders (Kazdin, 
2015). As a result, more automated and easy-to-disseminate ways to 
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deliver psychological treatments have emerged in the past two decades. 
These treatments include, for example, psychological treatments that 
are partly or completely delivered through the telephone, the Internet, 
an app, or a combination of media, although most of the effort has been 
dedicated to Internet-delivered treatments and, increasingly, app-based 
interventions (Mohr et al., 2017). 
Of the range of Internet-delivered psychological treatments, most of 
the research has focused on the study of Internet-delivered Cognitive 
Behavior Therapy (iCBT). A large number of studies have demonstrated 
the efficacy and effectiveness of iCBT (Andrews et al., 2018; Carlbring 
et al., 2018). Although the effectiveness of iCBT has been relatively well 
established, less is known about the characteristics that moderate or 
predict treatment success or failure in iCBT. The study of predictors and 
moderators of treatment outcomes plays an important role in psycho-
therapy research because the same treatment is not likely to work for 
everyone in the same way (Kazdin, 2014). To date, predictors and 
moderators of treatment outcomes have generally included patients' 
sociodemographic characteristics (e.g., age, sex, educational level) and 
clinical status (e.g., symptom severity, diagnosis) (El Alaoui et al., 2013; 
Webb et al., 2017). However, in recent years, and especially with the 
advent of self-administered interventions, researchers have also shown 
interest in adherence and compliance parameters as potential predictors 
and moderators of Internet-delivered psychotherapy. The relationship 
between treatment adherence and treatment outcomes has been high-
lighted as a critical aspect in the literature on Internet-delivered in-
terventions (Christensen et al., 2009; Van Ballegooijen et al., 2014). 
However, findings on this relationship remain unclear due to the het-
erogeneity in the adherence indicators used in these studies (Donkin 
et al., 2011; Sieverink et al., 2017). Adherence is often defined as a 
function of the dropout rate (the number of participants who do not 
complete the treatment) or treatment compliance (i.e., whether the 
patient completes the treatment in accordance with the study goals) 
(Donkin et al., 2013). The importance of treatment compliance in terms 
of adherence to the prescribed use of the platform (e.g., number of 
modules completed and use of the review content) is less clear. This is a 
key issue because finishing an Internet-delivered treatment (i.e., 
completing all the treatment modules) does not necessarily mean that 
the patient is actively using the intervention. For instance, research has 
found low or no usage, even in patients who do not drop out of Internet 
interventions (Christensen and Mackinnon, 2006). Therefore, a wider 
range of adherence aspects, such as the patients' level of activity or 
engagement with the program, deserve more research attention in iCBT. 
An advantage of iCBT is that it facilitates data collection (Andersson and 
Titov, 2014). For instance, Internet-delivered interventions can easily 
collect objective data related to platform usage, such as the number of 
logins, the number of modules completed, or the time spent using the 
program (for a review of measures of usage and adherence, see Donkin 
et al., 2011). This information may help to analyze whether there is a 
dose-response relationship between usage and treatment outcomes 
(Sieverink et al., 2017). 
To date, the relationship between platform usage and treatment 
outcomes has been examined in a number of studies (Manwaring et al., 
2008; Enrique et al., 2019; Couper et al., 2010; Donkin et al., 2013; Fuhr 
et al., 2018). For example, Donkin et al. (2013) found that the number of 
activities completed per login was associated with outcome improve-
ment. In another study, Enrique et al. (2019) showed that patients who 
achieved clinically meaningful changes after completing iCBT for 
depression were, in general, more engaged with the program than those 
who did not experience these changes (including time spent using the 
platform, number of logins, percentage of treatment completion, and 
number of activities performed). In sum, the literature suggests that 
there is a positive relationship between platform usage and treatment 
outcomes, and that these metrics might be used to establish a dose- 
response relationship. For example, Enrique et al. (2019) showed that 
at least 7 h of platform usage distributed over 15 sessions and the 
completion of 30 activities during a period of 12 weeks predicted a 
clinically significant change in patients with emotional disorders. 
Another important feature of iCBT that may have a considerable 
impact on treatment adherence and treatment outcomes is the nature 
and degree of the guidance provided to participants (Andersson, 2018). 
It is generally assumed that some guidance in Internet interventions is 
more beneficial than completely self-guided interventions. It is impor-
tant to note, however, that some studies have failed to find an associa-
tion between guidance and outcomes in iCBT research. For example, a 
study by Mira et al. (2017) did not show significant differences between 
guided and unguided psychotherapy in an Internet-delivered treatment 
for mild to moderate depression. Similarly, a study that implemented an 
iCBT intervention for tinnitus found similar levels of treatment efficacy 
in patients with and without guidance (Rheker et al., 2015). Neverthe-
less, most of the available evidence suggests that there is a significant 
relationship between guidance and treatment outcomes (Baumeister 
et al., 2014; Palmqvist et al., 2007). Additionally, the amount of guid-
ance in iCBT seems to be associated with the magnitude of treatment 
outcomes in a linear way, that is, patients who receive more guidance 
appear to show greater improvement (Richards and Richardson, 2012). 
Research also suggests that clinician-guided iCBT (i.e., guidance in-
cludes the delivery of some clinical content) can be as effective as other 
types of guided iCBT where a clinical background is not necessary, such 
as technician-guided iCBT, which may include responding to technical 
questions or making general recommendations to guide a patient 
through an Internet-delivered intervention (Andersson et al., 2019; 
Richards and Richardson, 2012). However, even though the literature 
has shown the relationship between guidance and treatment outcomes, 
it is unclear whether there is an optimal amount of guidance that could 
predict the outcome response to iCBT (e.g., time spent on the phone with 
a therapist). 
In the current study, we conceptualized participants' level of 
engagement as patient involvement and treatment guidance as therapist 
involvement. The aim of the present investigation was to explore the 
relationship between patient and therapist involvement and the 
response to an iCBT intervention delivered in Spanish public mental 
health units (i.e., predicting changes in anxiety and depression symp-
toms in a sample of individuals with emotional disorders). Patient 
involvement variables included the number of times they logged into the 
program and the frequency with which they reviewed the treatment 
contents. Therapist involvement variables were measured as a function 
of the time spent during phone calls to provide guidance to the patient. 
Specifically, we aimed to explore whether the amount of patient 
involvement (i.e., platform usage) and clinician involvement (i.e., 
amount of guidance) predicted a clinically significant change in 
depressive and anxiety symptoms after iCBT. In doing so, we explored 
whether a recommended cut-off point can be obtained for both patient 
and therapist involvement. In general terms, the literature suggests that 
guided iCBT frequently leads to better outcomes than unguided iCBT 
(Baumeister et al., 2014; Palmqvist et al., 2007). Based on these find-
ings, we expected to find a positive relationship between patient 
involvement and reductions in symptomatology following iCBT. How-
ever, although there is some research that links the degree of guidance 
with the magnitude of the outcomes (e.g., Richards and Richardson, 
2012), the available evidence is still limited, and so the study of this 
relationship warrants further investigation. 
2. Methods 
2.1. Design 
This study is a secondary analysis of data from a randomized 
controlled trial (RCT) that compared transdiagnostic iCBT for emotional 
disorders with treatment as usual in public specialized mental health-
care services (González-Robles et al., 2015). Transdiagnostic iCBT for 
emotional disorders has been successfully tested in a large number of 
studies, showing that it is superior to waitlist conditions (Newby et al., 
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2016) and just as effective as face-to-face CBT (Newby et al., 2015). With 
regard to our RCT, the results supported the greater effectiveness of a 
transdiagnostic Internet-delivered protocol compared to specialized 
mental health care on measures of anxiety, depression, and quality of 
life (González-Robles et al., 2020). 
The trial was approved by the Ethics Committee of Universitat Jaume 
I (Castellón, Spain) and the Clinical Research Ethics Committees of the 
three participating hospitals (Consorcio Hospitalario Provincial de 
Castellón, Hospital Universitario de la Ribera, and Hospital Uni-
versitario Vall d'Hebron). The study protocol was registered at ClinicalT 
rials.gov as NCT02345668 on July 27, 2015. More details about the 
study protocol and the clinical trial can be found elsewhere (González- 
Robles et al., 2015, 2020). 
2.2. Participants and procedure 
The sample was composed of adult outpatients who sought treatment 
for depression or anxiety problems in Spanish public specialized mental 
health settings (mental health units). Potential candidates were identi-
fied by the clinicians working in these centers and assessed for eligibility 
by the study researchers. A detailed description of the recruitment 
process has been described elsewhere (González-Robles et al., 2020). To 
participate, individuals had to meet the following inclusion criteria: (1) 
be at least 18 years old; (2) be able to understand and read Spanish; (3) 
have an email address and access to the Internet at home; (4) meet 
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition 
(DSM-IV) diagnostic criteria [74] for an emotional disorder (i.e., major 
depressive disorder, dysthymic disorder, depression not otherwise 
specified, panic disorder, agoraphobia, social anxiety disorder, gener-
alized anxiety disorder, anxiety not otherwise specified, and obsessive- 
compulsive disorder); (5) provide written informed consent; (6) not 
suffer from a severe mental disorder (schizophrenia, bipolar disorder, 
and alcohol and/or substance dependence disorder); (7) not present a 
high suicide risk; (8) not suffer from a disabling medical disease that 
would keep the participant from carrying out the psychological treat-
ment; and (9) not be receiving another psychological treatment during 
the study. Pharmacological treatment was allowed, but participants had 
to be taking the same dose during the two months prior to enrolling in 
the study. In addition, changes or increases in the medication during the 
study period led to the participant's exclusion from the trial. All par-
ticipants provided written, informed consent to participate in the study. 
In all, 326 patients were interested in the study. Of them, 281 were 
assessed for eligibility, and 67 were excluded for eligibility reasons. The 
final sample consisted of 214 participants who were randomized to 
transdiagnostic iCBT (n = 106) or treatment as usual (n = 108). Reasons 
for exclusion in the transdiagnostic iCBT group included not meeting the 
diagnostic criteria for an emotional disorder (n = 37), the presence of 
substance and alcohol dependence disorders (n = 9), suicide risk (n = 7), 
and the presence of severe disorders such as bipolar disorder (n = 5) and 
psychotic disorders (n = 2). Finally, seven additional patients were 
excluded for a variety of reasons (n = 7). 
For the purposes of the present study, we only included the sample of 
patients who completed the Internet-delivered intervention. Specif-
ically, to be able to study the relationship between patient/therapist 
involvement and outcomes, participants in this study were included if 
they had completed at least 75% of the intervention (9 out of 12 mod-
ules). Most participants completed all modules (n = 54, 86%), one pa-
tient (1,6%) completed 11 modules, two patients (3%) completed 10 
modules, and six patients (9,5%) completed 9 modules. In this condi-
tion, 35 patients (33%) dropped out, seven patients were excluded 
because they withdrew before completing the baseline assessment, and 
data from one additional patient could not be retrieved. Therefore, the 
sample for this study consisted of 63 participants. 
2.3. Intervention 
The intervention was a 12-module, transdiagnostic guided Internet- 
delivered protocol for the treatment of emotional disorders. The proto-
col was delivered through a web platform (https://psicologiaytecnolo 
gia.com/) designed by our research group. The main core components 
are derived from the Unified Protocol (Barlow et al., 2011a, 2011b), but 
it also incorporates treatment strategies from Dialectical Behavioral 
Therapy (Linehan, 1993). The treatment is focused on teaching the in-
dividuals adaptive emotion regulation strategies through the following 
core components: present-focused emotional awareness, cognitive flex-
ibility, emotional avoidance and emotion-driven behaviors, and expo-
sure procedures (interoceptive and situational) (Modules 4 to 11). Most 
of the content in modules 4 to 11 was adapted from the Unified Protocol. 
However, modules 4 and 5 also incorporated Dialectical Behavioral 
Therapy techniques, such as mindfulness “what skills” (observing, 
describing, and participating) and “how techniques” (non-judgmentally, 
one-mindfully, and effectively). The protocol contains three additional 
modules (Modules 1 to 3). They include an introductory module, a 
module to promote the patient's engagement with the therapy (i.e., 
motivation to change), and a module with psychoeducation about 
emotions (e.g., nature and role of emotions). The protocol ends with a 
relapse prevention module (Module 12). The 12 treatment modules are 
preceded by a “Welcome module” with general information about the 
Table 1 
Objectives of the treatment modules.  
Module Objective 
Module 1. Introduction to treatment Provides a framework about the role of 
emotion regulation in emotional 
disorders. 
Module 2. Motivation for change and 
goal setting 
Analyzes pros and cons of changing, 
emphasizes the importance of being 
motivated, and helps to establish 
significant life goals. 
Module 3. Understanding the role of 
emotions 
Provides psychoeducation about the roles 
and functions of emotions and trains the 
patient to track the three components of 
emotional experiences. 
Module 4. Non-judgmental emotional 
awareness and acceptance of 
emotional experiences 
Teaches the patient non-judgmental 
emotional awareness (i.e., mindfulness 
“what” and “how” skills) and the 
acceptance of emotional experiences. 
Module 5. Practicing present-focused 
awareness 
Continues to practice the acceptance of 
emotional experiences and increase 
awareness of physical sensations, 
thoughts, emotions, and daily activities. 
Module 6. Learning to be flexible Focuses on identifying maladaptive ways 
of thinking (i.e. thinking traps). 
Module 7. Practicing cognitive 
flexibility 
Teaches patients strategies to modify 
thinking traps (i.e., cognitive 
reappraisal). Provides information about 
intrusive thoughts and how to deal with 
them. 
Module 8. Emotional avoidance Teaches patients to identify the emotion 
avoidance strategies that contribute to 
the maintenance of their emotional 
problems. 
Module 9. Emotion-Driven Behaviors Teaches the concept of emotion-driven 
behaviors and how to replace them with 
more adaptive behaviors. 
Module 10. Accepting and facing 
physical sensations 
Teaches the role of physical sensations in 
the emotional response and provides 
training in interoceptive exposure. 
Module 11. Facing emotions in the 
contexts in which they occur 
Builds exposure hierarchies to help 
patients begin to face situation-elicited 
avoided emotions. 
Module 12. Relapse prevention Reviews what patients have learned 
throughout the program. Schedules 
future practice of the learned strategies 
and teaches patients how to identify and 
cope with future high-risk situations.  
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protocol and its goals, as well as recommendations for how to use the 
program. The objectives of the modules are described in Table 1. 
Regarding the program structure, the modules are presented sequen-
tially (i.e., a module cannot be accessed until the previous one has been 
completed), and participants are encouraged to review the modules as 
often as they wish. Fig. 1 displays a screenshot of this functionality. 
2.3.1. Guidance 
All the participants received therapist and automated guidance. 
Therapist guidance included one weekly brief phone call with a 
maximum duration of 10 min. These weekly phone calls were previously 
scheduled with the patients and were conducted by two of the re-
searchers involved in the trial. Phone calls were not intended to address 
clinical content. The objectives of these phone calls were: 1) to explore 
difficulties or concerns the participants might have encountered while 
using the treatment and help them to solve these problems, 2) to remind 
them to review the treatment contents as often as necessary, 3) to 
emphasize the importance of completing the homework tasks, 4) to 
encourage the participants to keep using the protocol, as well as to 
reinforce them for engaging in the treatment, and 5) to recommend that 
they complete one module per week. 
Automated guidance consisted of a) 2 weekly brief text messages and 
b) guidance delivered throughout the treatment modules. Automated 
guidance included: a) reminders about the importance of reviewing the 
contents as needed, b) messages encouraging the user to complete the 
proposed activities in each module, c) messages with positive rein-
forcement after completing a module and when starting a new one, and 
d) messages to encourage the user to complete the treatment at an 
adequate pace (one module per week). 
For the purpose of this study, and because all the patients received 
the same amount of automated support, we only included therapist 
support (i.e., number of phone calls and their duration) in the analyses. 
2.4. Measures 
2.4.1. Primary outcome measures 
The Beck Anxiety Inventory (BAI) (Beck and Steer, 1993; Magán 
et al., 2008) is a 21-item self-report questionnaire that assesses anxiety. 
Scores can range from 0 to 63 points. Patients are asked to report on the 
severity of their symptoms during the previous week on a 4-point Likert 
scale (from not at all to severely). The BAI has shown good to excellent 
internal consistency in previous validation studies (alpha between 0.85 
and 0.94), as well as convergent and divergent validity. The Spanish 
version has demonstrated excellent internal consistency (α = 0.93; 
Magán et al., 2008). The Cronbach's α for the BAI in this study was 0.93. 
The Beck Depression Inventory, second edition (BDI-II) (Beck et al., 
1990; Sanz et al., 2005) is one of the most widely used instruments for 
the assessment of depressive symptoms. The scale contains 21 items 
about the different symptoms characterized in major depressive disor-
ders. Scores are added together to obtain a total score that can range 
between 0 and 63. The BDI-II has demonstrated good internal consis-
tency in previous research (α = 0.76–0.95). The Spanish version showed 
good internal consistency for both the general and clinical populations 
(alphas between 0.87 and 0.89; Sanz et al., 2005). The Cronbach's α for 
the BDI-II in this study was 0.91. 
2.4.2. Patient involvement (platform usage) metrics from the baseline 
assessment to post-treatment 
Number of sessions: This metric was established to register the times 
the patient logged in or accessed the treatment platform. When a specific 
session had inactivity periods longer than 60 min, the next moment of 
activity was counted as a new login. 
Number of reviews: This metric included the number of times the 
patients reviewed the modules, that is, the number of times they reop-
ened a given module after the first login. Therefore, this count did not 
include the first time the patient accessed each module. 
Fig. 1. Screenshot of the treatment platform. Patients have the option to review (“repasar”) the modules.  
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2.4.3. Therapist involvement (guidance) 
All patients received a weekly phone call with a maximum duration 
of 10 min. Because some of the scheduled phone calls were unanswered, 
the analysis of therapist involvement included a) the number of phone 
calls that were successfully completed and b) the total duration of all the 
calls received during the treatment. 
2.5. Analytic procedures 
First, the sample characteristics were described (means and standard 
deviations of study variables). Next, the bivariate associations between 
usage (logins and reviews made), guidance (number and duration of 
phone calls), and clinical variables (baseline depression and anxiety and 
their change scores after treatment) were calculated by means of Pear-
son correlations. To calculate changes in depression and anxiety to 
include them in the Pearson correlations, we subtracted post scores from 
pre scores (e.g., change in depression = post-treatment depression – 
pretreatment depression). Therefore, negative scores reflect a reduction 
in symptomatology (i.e., improvement). 
Finally, two types of analyses were performed to explore whether 
clinically significant changes (CSC) in outcomes were predicted by pa-
tient platform usage and guidance. First, a logistic regression was 
computed to explore the extent to which more practice and guidance 
helped to classify those who presented a clinically significant reduction 
in symptomatology (depression and anxiety). Second, a receiver oper-
ating characteristic (ROC) curve was calculated to obtain sensitivity and 
specificity scores that would reveal optimal levels of practice and 
guidance (cut-offs). 
A clinically significant change in outcomes was considered to occur 
when a person moved at least two standard deviations from the mean of 
the group (Jacobson et al., 1984). Because the sample included patients 
presenting quite diverse symptom severity (i.e., mild, moderate, or se-
vere), for each outcome, the analysis of the clinically significant change 
was carried out with each of the three subgroups according to symp-
tomatology severity. For example, for depression, cut-offs have been 
proposed to be 14–19 for mild depression, 20–28 for moderate depres-
sion, and above 28 for severe depression (Sanz et al., 2014). For each of 
these subgroups, a separate mean and standard deviation was calcu-
lated, and these values were used to decide whether a patient in that 
subgroup presented a clinically significant change. The same procedure 
was followed for anxiety scores using the recommended cut-offs for mild 
(between 8 and 15), moderate (between 16 and 25), and severe (above 
26) anxiety (Sanz et al., 2012). 
All analyses were performed with SPSS version 22 (IBM Corp, 2013). 
Alpha levels were set at 0.01 to reduce the risk of unimportant effects 
and false positives when conducting multiple comparisons. 
3. Results 
3.1. Sample characteristics 
Table 2 shows the baseline sociodemographic and clinical charac-
teristics of the sample. 
3.2. Patient and therapist involvement results (platform usage and 
guidance) 
In terms of practice, study participants logged into the treatment and 
accessed the review content a median of 28 (mean = 30.4, SD = 26.0) 
and 2 times (mean = 12.6, SD = 18.6), respectively. Regarding guid-
ance, participants received a median of 8 calls (mean = 7.2, SD = 4.1). 
The phone calls to the participants had a total median duration of 48.9 
min (mean = 37.2, SD = 41.0). Table 3 shows the bivariate association 
between platform usage (logins and reviews of content), guidance var-
iables (minutes during phone calls), and the clinical characteristics of 
the sample (baseline depressive and anxiety symptoms and changes in 
both outcomes after the treatment). The Pearson correlations revealed a 
significant and positive relationship between the number of phone calls 
received and the number of times participants accessed the platform (r 
= 0.61; p < .001) and reviewed the content (r = 0.46; p < .001). Simi-
larly, a significant and positive relationship was observed between the 
time spent during the phone calls and the number of times patients 
logged into the platform (r = 0.61, p < .001) and reviewed the modules 
during the treatment (r = 0.60; p < .001). There was also a significant 
relationship between the number of phone calls and their total duration 
at the end of the study (r = 0.80; p < .001), as well as between the 
number of logins to the platform and the number of times they reviewed 
the content (r = 0.84, p < .001). 
Regarding clinical variables, patients who were more depressed at 
baseline were more likely to improve on depression after completing the 
treatment (r = − 0.37, p = .003). The same relationship was found be-
tween baseline anxiety and anxiety improvement at post-treatment (r =
− 0.48, p < .001). 
Neither baseline levels of depression and anxiety nor changes in 
these outcomes after treatment were linearly associated with platform 
usage and guidance variables (all p > .01). Establishing a less restrictive 
alpha level, the results would show that patients who were more 
depressed at baseline received more guidance, that is, longer phone calls 
Table 2 
Baseline and sociodemographic characteristics of the sample (N = 63).  
Age (years), mean (SD) 38.64 (10.61) 
Sex, n (%) Female 42 (66.7) 
Male 21 (33.3) 
Marital status, n (%) Single 13 (20.6) 
Married/partnered 41 (65.1) 
Divorced/widowed 9 (14.3) 
Education, n (%) Basic studies 16 (25.4) 
Secondary studies 22 (34.9) 
University studies 25 (39.7) 
Occupation, n (%) Student 3 (4.8) 
Housekeeper 4 (6.3) 
Employed 34 (54) 
Unemployed 13 (20.6) 
Off work 8 (12.7) 
Retired 1 (1.6) 
Monthly income (€), n (%) None 13 (20.6) 
<641.40 9 (14.3) 
641.40–1282.80 25 (39.7) 
1282.81–2565.60 15 (23.8) 
>2565.60 1 (1.6) 
Principal diagnosis, n (%) GAD 15 (23.8) 
AG 5 (7.9) 
PD 10 (15.9) 
SAD 3 (4.8) 
OCD 3 (4.8) 
MDD 11 (17.5) 
DD 6 (9.5) 
Anxiety NOS 10 (15.9) 







Anxiety/depression NOS 2 
Alcohol abuse 1 
Number of comorbid disorders, n (%) 0 36 (57.1) 
1 15 (23.8) 
2 7 (11.1) 
≥3 5 (7.9) 
Medication, n (%) None 16 (25.4) 
Antidepressant 14 (22.2) 
Anxiolytic 9 (14.3) 
Both 24 (38.1) 
GAD: Generalized anxiety disorder; PD: Panic disorder; AG: Agoraphobia; SAD; 
Social anxiety disorder; OCD: Obsessive-compulsive disorder; MDD: Major 
depressive disorder; DD: Dysthymic disorder; NOS: Not otherwise specified. 
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(r = 0.22, p = .034). 
3.3. Percentage of individuals presenting a CSC in symptoms 
A CSC in depressive and anxiety symptoms was obtained by 61.7% 
and 41.5% of participants, respectively. 
In the mild (n = 9), moderate (n = 17), and severe depression groups 
(n = 22), a CSC was obtained by 77.8%, 64.7%, and 54.5% of partici-
pants, respectively. In the mild (n = 19), moderate (n = 12), and severe 
depression groups (n = 22), a CSC was reported by 47.4%, 66.7%, and 
22.7% of participants, respectively. 
3.4. Predicting CSC classification based on patient and therapist 
involvement: logistic regression and ROC analysis 
Neither patient nor therapist involvement predicted the classifica-
tion of CSCs in depressive or anxiety symptoms (Table 4). 
The results of the ROC analyses, reported in Table 5, revealed that 
none of the predictions had sufficient classification capacity (all areas 
under the curve were below 0.5 and non-significant). Therefore, no 
value of platform usage and guidance had an adequate sensitivity and 
specificity ratio. 
4. Discussion 
The current study analyzed the role of patient and therapist 
involvement in the effectiveness of transdiagnostic iCBT for patients 
with emotional disorders attending Spanish specialized mental health-
care services. Patient involvement variables included platform usage 
factors, that is, how many times the patients logged into the program 
and how often they reviewed the treatment contents. Therapist 
involvement was evaluated as the number of phone calls with a therapist 
throughout the treatment, as well as their duration. Overall, the results 
do not show that the amount of patient and therapist involvement pre-
dicted symptom reduction after a transdiagnostic iCBT. In this line, no 
cut-off point was found that could differentiate those who presented a 
clinically significant reduction in symptoms from those who did not. 
In terms of patient involvement, the results obtained in this study 
suggest that the amount of platform usage, defined as the number of 
logins and the number of module reviews, does not predict the patients' 
response to transdiagnostic iCBT. Our results differ from other studies 
that found a relationship between platform usage and outcomes in iCBT 
(e.g., Manwaring et al., 2008; Enrique et al., 2019; Donkin et al., 2013; 
Fuhr et al., 2018). However, it is important to note that the relationship 
between usage and outcomes in the existing literature is not consistent 
across measures, and it is related to the type of usage metric selected. For 
instance, Manwaring et al. (2008) found that the amount of platform 
usage predicted specific eating-disorder symptom improvement in a 
sample with eating disorders but no other related clinical symptoms. In 
another study that tested Internet-delivered psychotherapy for depres-
sion, the association between various usage metrics and treatment out-
comes was analyzed. The results showed that only one usage metric was 
associated with the treatment outcome (i.e., the number of activities 
completed per login), whereas other measures, such as the number of 
logins or the number of activities completed, were not related to 
symptom reduction (Donkin et al., 2013). In our study, the fact that we 
failed to find a significant relationship between usage and symptom 
improvement might be explained by the metrics selected in the present 
investigation. For example, it is possible that the number of logins and 
reviews does not provide information about what the participants do 
when they log into the platform or review the treatment modules. 
Specifically, a patient might login quite frequently, but the number of 
logins per se might not provide information about how the patient is 
actually using the treatment (e.g., how much the patient is using the 
treatment strategies in real contexts or whether the patient performs the 
suggested activities). In other words, the patient might be using the 
program passively rather than actively (Enrique et al., 2019). 
With regard to guidance, no relationship was observed between the 
amount of guidance received (number and duration of phone calls) and 
the treatment outcome. To date, the iCBT literature has generally been 
interested in comparing therapy with and without therapist guidance, 
generally supporting the idea that some therapist guidance is preferable 
(Aardoom et al., 2016; Baumeister et al., 2014; Palmqvist et al., 2007). 
What is less clear is how much guidance is necessary or optimal and 
which sources of guidance are preferable (e.g., phone calls, emails, text 
messages, etc.). This is important in terms of costs (e.g., texts can be 
more automatized and require less therapist involvement). Our results 
do not support the idea that certain levels of support are better than 
others, which suggests that the amount of therapist involvement will 
require some flexibility depending on the patient's response to iCBT. 
Table 3 
Correlations between platform usage, guidance, and clinical outcomes.   
Mean (SD) Reviews Number of calls Duration of calls Change BDI-II Change BAI BDI-II (baseline) BAI (baseline) 
Logins 30.39 (25.99)  0.84**  0.61**  0.61**  0.10  0.15  0.03  0.04 
Reviews 12.55 (18.63)   0.46**  0.60**  0.01  0.14  − 0.02  − 0.06 
Number of calls 7.21 (4.12)    0.80**  − 0.19  − 0.01  0.10  0.10 
Duration of calls 48.94 (40.98)     − 0.06  0.06  0.21  0.09 
Change BDI-II − 9.03 (9.82)      0.42**  − 0.37*  − 0.08 
Change BAI − 6.41 (9.77)       − 0.05  − 0.48** 
Baseline BDI-II 23.70 (11.03)        0.39** 
Baseline BAI 20.14 (11.96)        
* p < .01, ** p < .001. Duration of calls represented in minutes. Change scores are calculated as post scores – pre scores, so that negative scores indicate a reduction in 
symptomatology (i.e., improvement). BDI-II: Beck Depression Inventory (2nd edition); BAI: Beck Anxiety Inventory. 
Table 4 
Binary logistic regression predicting the classification of CSCs in depressive and 
anxiety symptoms.   
CSC in depressive symptoms CSC in anxiety symptoms 
Beta P Beta P 
Logins  − 0.03  0.254  − 0.03  0.165 
Reviews  0.04  0.200  0.02  0.510 
Number of calls  − 0.16  0.299  0.12  0.447 
Duration of calls  − 0.02  0.095  − 0.01  0.501 
CSC: Clinically significant change. 
Nagelkerke's R2 for depressive and anxiety symptoms were 0.12 and 0.08, 
respectively. 
Table 5 
Receiver operating characteristic curve analyses.   
CSC in depressive symptoms CSC in anxiety symptoms 
AUC P AUC P 
Logins  0.45  0.597  0.37  0.119 
Reviews  0.44  0.485  0.41  0.284 
Number calls  0.47  0.768  0.49  0.914 
Duration calls  0.41  0.322  0.42  0.354 
CSC: clinically significant change; AUC: area under the curve. 
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An interesting finding was that the patients' severity before treat-
ment onset did not predict prospective patient and therapist involve-
ment. One might assume that patients experiencing more severe 
symptomatology would require more guidance (i.e., more frequent and 
longer phone calls) and have to check the treatment content more often 
(more logins into the platform and more reviews of the content). 
Interestingly, however, the severity of anxiety and depressive symptoms 
was unrelated to patient and clinical involvement, which suggests that 
additional factors should be investigated to explore individual differ-
ences in patient and therapist involvement in iCBT. In terms of patient 
involvement, several factors might influence platform usage, such as 
personality characteristics (e.g., intrinsic vs. extrinsic motivation) 
(Arnold et al., 2019) or contextual variables (e.g., time available to 
revise the content and quality of the technology used to visualize the 
treatment) (Fernández-Álvarez et al., 2017). Similarly, personality 
characteristics (e.g., neuroticism) and contextual factors (e.g., previous 
experience with Internet-delivered treatments) (Wallin et al., 2016) 
could predict the amount of clinician involvement patients need. How-
ever, it is worth to note that, when a less restrictive alpha was considered 
(i.e., p < .05), baseline depression was significantly associated with 
therapist involvement (longer phone calls). Taken together, these find-
ings suggest that the extent to which these and other variables predict 
patient and therapist involvement in iCBT requires further investigation. 
Along the same lines, the lack of relationship between guidance and 
outcomes in this study might be partly accounted for by the bond be-
tween the online platform and the patient, in other words, the partici-
pants' therapeutic alliance with the online program (Herrero et al., 
2020). Research has shown that, as in face-to-face psychotherapy, pa-
tients in Internet-delivered interventions are able to develop a bond with 
the online program (Berry et al., 2018), and this relationship is posi-
tively associated with treatment outcomes and satisfaction with the 
treatment (Gómez-Penedo et al., 2020; Pihlaja et al., 2018). Thus, it is 
important to note that, in the current study, guidance (phone calls) did 
not include clinical content. In other words, phone calls were focused on 
aspects such as resolving specific questions about the use of the plat-
form, reminders about the importance of practicing, positive rein-
forcement for completing the modules, and so on, aspects that were also 
present in the treatment modules as “automated support” (see the 
Intervention section). It is possible that participants in this study had 
high levels of therapeutic alliance with the online program (i.e., patients 
may have benefited from automated guidance) and, therefore, that the 
specific type of therapist guidance provided in this study did not add 
anything to the intervention in terms of symptom improvement. More-
over, because both therapist and automated guidance had similar con-
tent, the specific influence of each guidance modality (therapist vs. 
automated) on treatment outcomes could not be ascertained. In any 
case, the literature suggests that the presence of some type of human 
contact in an Internet-delivered treatment seems necessary for some 
patients to foster their participation and adherence (Fernández-Álvarez 
et al., 2017; Schueller et al., 2017), which are core aspects in research on 
Internet-delivered interventions. 
In the present study, the relationship between patient involvement 
(e.g., platform usage) and therapist involvement (i.e., guidance) was 
also investigated. On the one hand, the number of sessions (logins) was 
strongly associated with the number of reviews. That is, patients who 
used the program more frequently also tended to review the treatment 
modules more often. On the other hand, time spent on the phone was 
associated with higher levels of platform usage (number of logins and 
number of module reviews). At a glance, therapist involvement seems to 
increase the levels of patient involvement with the platform. That is, 
patients who spent more time on the phone may have presented greater 
platform usage because they received more positive reinforcement and 
had more reminders about the importance of practicing. Another pos-
sibility is that this relationship reflects the different level of engagement 
shown by the participants. Specifically, it is possible that patients with 
greater availability or interest in using the platform were also more 
willing to spend time on the phone. In any case, we only measured the 
number of logins and the number of module reviews, but we did not 
collect data about the specific behaviors that are assumed to cause 
clinical change. These might include, for example, to what degree par-
ticipants understand the different components or whether participants 
actively and correctly completed the proposed strategies (e.g., exposure 
procedures, cognitive flexibility techniques, and so on). Given the un-
deniable importance of these variables, future research should strive to 
integrate assessment strategies (e.g., Ecological Momentary Assessment, 
EMA) (Colombo et al., 2020) to analyze how these aspects are related to 
treatment outcomes in iCBT. For example, specific EMAs might include 
questions about whether a specific treatment strategy (e.g., an intero-
ceptive exposure task) has been practiced at a certain moment, or how 
many times specific techniques have been practiced throughout the day. 
Similarly, Ecological Momentary Interventions (EMI) (Heron and 
Smyth, 2010) might be used to monitor whether the homework is 
actively carried out by participants (e.g., a notification in the mobile 
phone that encourages the patients to do the homework and asks them to 
provide data about their emotions and thoughts after an exposure task). 
Our study has limitations. First and foremost, some relevant metrics, 
such as the time spent using the different modules or the time spent 
reviewing the modules, could not be analyzed. This limitation was due 
to technical characteristics of the treatment platform rather than to a 
study design flaw. Second, because only completers were included in the 
analyses, the sample size was small, which limits the generalizability of 
the results. Third, analyses could not be separated according to the 
diagnosis because of sample size limitations and frequent comorbidities. 
Finally, the design of the current study does not allow separating the 
specific effects of therapist guidance vs. automated guidance in treat-
ment outcomes. 
To conclude, our study found no relationship between patient 
involvement (i.e., platform usage) and therapist involvement (i.e., 
guidance) in predicting the response to transdiagnostic iCBT for 
reducing depressive and anxiety symptoms in patients with emotional 
disorders. Thus, our findings do not support the idea that patients should 
be given specific recommendations in terms of platform usage, at least in 
terms of the variables analyzed in this study (i.e., number of logins and 
number of reviews of the contents). Moreover, therapist support should 
be provided flexibly depending on the patient and the situation. These 
results shed new light on the role of patient and therapist involvement in 
iCBT. Although patient and therapist involvement may be important, as 
reported in the literature, specific cut-offs might be difficult to establish 
(or unnecessary), at least for some usage metrics. More research is 
warranted to explore this specific aspect. Moreover, our findings suggest 
that therapist involvement is important for patient involvement in iCBT. 
Based on our findings, we believe that the interrelationship between the 
therapist and patient involvement variables, as well as the role of this 
relationship in treatment outcomes, is an important area of research that 
should be further explored. We encourage researchers to replicate the 
current study findings and include additional patient and therapist 
involvement metrics to provide a more comprehensive view of patient 
and therapist factors that predict response to iCBT, which is crucial for 
enhancing the effectiveness of these interventions. Finally, we suggest 
that future studies move beyond the traditional assessment and treat-
ment approaches by integrating EMAs and EMIs to examine the rela-
tionship between therapist and patient involvement factors and 
outcomes in Internet-delivered interventions. 
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A. González-Robles et al.                                                                                                                                                                                                                      
Internet Interventions 25 (2021) 100420
8
Declaration of competing interest 
The authors declare that they have no known competing financial 
interests or personal relationships that could have appeared to influence 
the work reported in this paper. 
References 
Aardoom, J.J., Dingemans, A.E., Spinhoven, P., van Ginkel, J.R., de Rooij, M., van 
Furth, E.F., 2016. Web-based fully automated self-help with different levels of 
therapist support for individuals with eating disorder symptoms: a randomized 
controlled trial. J. Med. Internet Res. 18 (6), e159. 
Andersson, G., 2018. Internet interventions: past, present and future. Internet Interv. 12, 
181–188. 
Andersson, G., Titov, N., 2014. Advantages and limitations of internet-based 
interventions for common mental disorders. World Psychiatry 13 (1), 4–11. 
Andersson, G., Titov, N., Dear, B.F., Rozental, A., Carlbring, P., 2019. Internet-delivered 
psychological treatments: from innovation to implementation. World Psychiatry 18 
(1), 20–28. 
Andrews, G., Basu, A., Cuijpers, P., Craske, M.G., McEvoy, P., English, C.L., Newby, J.M., 
2018. Computer therapy for the anxiety and depression disorders is effective, 
acceptable and practical health care: an updated meta-analysis. J. Anxiety Disord. 
55, 70–78. 
Arnold, C., Villagonzalo, K.A., Meyer, D., Farhall, J., Foley, F., Kyrios, M., Thomas, N., 
2019. Predicting engagement with an online psychosocial intervention for psychosis: 
exploring individual-and intervention-level predictors. Internet Interv. 18, 100266. 
Barlow, D.H., Ellard, K.K., Fairholme, C.P., Farchione, T.J., Boisseau, C.L., Allen, L.B., 
Ehrenreich-May, J., 2011a. The Unified Protocol for Transdiagnostic Treatment of 
Emotional Disorders: Client Workbook. Oxford University Press, New York.  
Barlow, D.H., Farchione, T.J., Fairholme, C.P., Ellard, K.K., Boisseau, C.L., Allen, L.B., 
Ehrenreich-May, J., 2011b. Treatments that Work. Unified Protocol for 
Transdiagnostic Treatment of Emotional Disorders: Therapist Guide. Oxford 
University Press, New York, NY, US.  
Baumeister, H., Reichler, L., Munzinger, M., Lin, J., 2014. The impact of guidance on 
Internet-based mental health interventions—a systematic review. Internet Interv. 1 
(4), 205–215. 
Baxter, A.J., Scott, K.M., Ferrari, A.J., Norman, R.E., Vos, T., Whiteford, H.A., 2014. 
Challenging the myth of an “epidemic” of common mental disorders: trends in the 
global prevalence of anxiety and depression between 1990 and 2010. Depress. 
Anxiety 31 (6), 506–516. 
Beck, A.T., Steer, R.A., 1993. Beck Anxiety Inventory Manual. Psychological Corporation, 
San Antonio, TX.  
Beck, A.T., Steer, R.A., Brown, G.K., 1990. Manual for the Beck Depression Inventory–II. 
Psychological Corporation, San Antonio, TX.  
Berry, K., Salter, A., Morris, R., James, S., Bucci, S., 2018. Assessing therapeutic alliance 
in the context of mHealth interventions for mental health problems: development of 
the mobile Agnew relationship measure (mARM) questionnaire. J. Med. Internet 
Res. 20 (4), e90. 
Bullis, J.R., Boettcher, H., Sauer-Zavala, S., Farchione, T.J., Barlow, D.H., 2019. What is 
an emotional disorder? A transdiagnostic mechanistic definition with implications 
for assessment, treatment, and prevention. Clin. Psychol. Sci. Pract. 26 (2), e12278. 
Carlbring, P., Andersson, G., Cuijpers, P., Riper, H., Hedman-Lagerlöf, E., 2018. Internet- 
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